Comments on EMIP-FR study's editorial.
作者信息
Szwed H
出版信息
Eur Heart J. 2001 Aug;22(15):1359. doi: 10.1053/euhj.2001.2539.
PMID:11465969
Abstract
摘要
相似文献
1
Comments on EMIP-FR study's editorial.
Eur Heart J. 2001 Aug;22(15):1359. doi: 10.1053/euhj.2001.2539.
2
The EMIP-FR Study: the evolution of scientific background as a non-controlled parameter.
Eur Heart J. 2001 Jun;22(11):975-7; author reply 978. doi: 10.1053/euhj.2000.2528.
3
About EMIP-FR and reperfusion damage in AMI: a comment to the comment.
Eur Heart J. 2001 Jun;22(11):973-5; author reply 978. doi: 10.1053/euhj.2000.2489.
4
The EMIP project. European Myocardial Infarction Project.
Eur Heart J. 2000 Sep;21(18):1498-9. doi: 10.1053/euhj.2000.2230.
5
[The use of trimetazidine in the combined therapy of postinfarct stenocardia].
Ter Arkh. 1997;69(1):68-9.
6
Angina, myocardial hibernation and trimetazidine.
Int J Clin Pract. 1997 Sep;51(6):347.
7
[Treatment of stable angina pectoris with trimetazidine].
Vnitr Lek. 2006 Jun;52(6):556-7.
8
9
[Modulation of myocardial metabolism with trimetazidine].
Vnitr Lek. 2006 Jun;52(6):558-9.
10
Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
Am J Cardiol. 2006 Sep 4;98(5A):8J-13J. doi: 10.1016/j.amjcard.2006.07.003. Epub 2006 Jul 24.
Zotero 插件